Cargando…
A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
BACKGROUND: Pulmonary arterial hypertension is a major cause of death in systemic lupus erythematosus, but there are no tools specialized for predicting survival in systemic lupus erythematosus-associated pulmonary arterial hypertension. RESEARCH QUESTION: To develop a practical model for predicting...
Autores principales: | Qu, Jingge, Li, Mengtao, Zhang, Xiao, Zhang, Miaojia, Zuo, Xiaoxia, Zhu, Ping, Ye, Shuang, Zhang, Wei, Zheng, Yi, Qi, Wufang, Li, Yang, Zhang, Zhuoli, Ding, Feng, Gu, Jieruo, Liu, Yi, Qian, Junyan, Huang, Can, Zhao, Jiuliang, Wang, Qian, Liu, Yongtai, Tian, Zhuang, Wang, Yanhong, Wei, Wei, Zeng, Xiaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492375/ https://www.ncbi.nlm.nih.gov/pubmed/37689662 http://dx.doi.org/10.1186/s12931-023-02522-2 |
Ejemplares similares
-
Risk assessment in systemic lupus erythematosus-associated pulmonary
arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022) -
Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021) -
Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry
por: Wang, Ziqian, et al.
Publicado: (2021) -
Chinese SLE Treatment and Research Group (CSTAR) Registry 2009–2019: Major Clinical Characteristics of Chinese Patients with Systemic Lupus Erythematosus
por: Li, Mengtao, et al.
Publicado: (2021) -
Sirolimus versus tacrolimus for systemic lupus erythematosus treatment: results from a real-world CSTAR cohort study
por: Jiang, Nan, et al.
Publicado: (2022)